UK Rare Disease Drug Review Reform Urged As Spinraza Finally Gets NICE OK

 
• By Kevin Grogan
Stethoscope_Coins
NICE has now recommended funding for Biogen's Spinraza • Source: Shutterstock

More from Health Technology Assessment

More from Market Access